Current clinical trials in renal cell carcinoma

Mitchell H. Sokoloff, Siamak Daneshmand, Christopher W. Ryan

    Research output: Contribution to journalReview articlepeer-review

    6 Scopus citations


    The treatment of renal cell carcinoma remains primarily surgical. Consequently, it is not surprising that urologists have been active in the design and operation of clinical trials for patients with kidney cancer. Currently, clinical trial efforts of the urologic community are focused on the adjuvant setting in patients undergoing nephrectomy at high risk for recurrence or metastasis. As newer agents become available and are applied earlier during the course of the disease, the involvement of urologists in clinical trials in renal cell carcinoma will increase. This review highlights several key trials currently available for patients with kidney cancer.

    Original languageEnglish (US)
    Pages (from-to)289-292
    Number of pages4
    JournalUrologic Oncology: Seminars and Original Investigations
    Issue number4
    StatePublished - Jul 1 2005


    • Clinical trials
    • Kidney cancer
    • Nephrectomy
    • Targeted therapy

    ASJC Scopus subject areas

    • Oncology
    • Urology


    Dive into the research topics of 'Current clinical trials in renal cell carcinoma'. Together they form a unique fingerprint.

    Cite this